ArticleEpilepsy & behavior reports2025
A case of neurosarcoidosis presenting as hippocampal sclerosis: Clinicopathological correlation and proposed mechanistic link.
Article in Epilepsy & behavior reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurosarcoidosis is a rare manifestation of systemic sarcoidosis, typically affecting the meninges, cranial nerves, and hypothalamic-pituitary axis. Parenchymal brain involvement-particularly of the hippocampus-is uncommon and only rarely associated with epilepsy or hippocampal sclerosis (HS). Here, we describe a rare coexistence of biopsy-proven neurosarcoidosis and hippocampal sclerosis, suggesting secondary hippocampal injury due to chronic inflammation presenting with drug-resistant right mesial temporal lobe epilepsy (MTLE). We reviewed the clinical electrophysiological imaging and histopathological findings of a 47-year-old male who underwent anterior temporal lobectomy (ATL) after seizure onset which was localized to the right anterior to mid temporal region. Preoperative MRI was consistent with mesial temporal sclerosis. Histopathological analysis revealed both classic features of HS (neuronal loss and gliosis) and non-caseating granulomas diagnostic of neurosarcoidosis distributed within the medial temporal lobe and involving the amygdala. These findings suggest chronic inflammation may have contributed to hippocampal injury and epileptogenesis. The patient became seizure-free postoperatively. This case underscores the potential for neurosarcoidosis to mimic isolated MTLE and coexist with HS as a rare co-localized pathology. It raises the hypothesis that immune-mediated inflammation may play a pathogenic role in hippocampal degeneration. Recognition of such cases may enhance diagnostic accuracy and inform surgical planning in epilepsy associated with systemic inflammatory disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.